Melatonin prevents obesity through modulation of gut microbiota in miceOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether melatonin's known ability to reduce body weight and improve energy balance is linked to changes in the gut microbiota. Mice were fed a high fat diet (HFD) to induce obesity, and melatonin was administered to test its effects on body weight, liver steatosis, low-grade inflammation, and insulin resistance. High-throughput pyrosequencing of the 16S rRNA gene was used to characterize shifts in gut microbiota composition following melatonin treatment. The study compared microbiota profiles across HFD, melatonin-treated HFD, and normal chow diet (NCD) groups.
Who was studied?
The subjects were mice fed either a high fat diet or a normal chow diet, with a subset of high fat diet mice receiving melatonin supplementation. The abstract does not specify the number of animals, their strain, sex, or age. This was an animal model study rather than a human cohort, designed to isolate diet and melatonin effects on the gut microbiota.
What were the most important findings?
Melatonin reduced body weight, liver steatosis, and low-grade inflammation, and improved insulin resistance in HFD-fed mice. High fat diet feeding altered 69 operational taxonomic units (OTUs) compared to the normal chow diet group, and melatonin supplementation reversed 14 of these OTUs back toward the NCD configuration. Melatonin decreased overall richness and diversity of the gut microbiota, lowered the Firmicutes-to-Bacteroidetes ratio, and increased the abundance of the mucin-degrading bacterium Akkermansia, which is associated with healthy mucosa. The abstract does not report findings related to Desulfovibrio, sulfate-reducing bacteria, hydrogen sulfide, or sulfur metabolism.
What are the greatest implications of this study?
The findings suggest that melatonin's protective effects against diet-induced obesity and metabolic dysfunction may be mediated in part through remodeling of the gut microbiota. The partial reversal of HFD-induced OTU changes and the boost in Akkermansia point to a plausible microbiota-mediated pathway supporting mucosal health and metabolic improvement. This positions melatonin as a candidate modulator of gut microbiota composition in the context of obesity, warranting further mechanistic and translational research.